Picard Medical, Inc. (PMI)
| Market Cap | 16.16M -91.9% |
| Revenue (ttm) | 5.33M +11.8% |
| Net Income | -18.21M |
| EPS | -10.27 |
| Shares Out | 2.34M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 29,979 |
| Open | 7.61 |
| Previous Close | 7.24 |
| Day's Range | 6.41 - 7.90 |
| 52-Week Range | 2.65 - 208.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 16, 2026 |
About PMI
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard ... [Read more]
Financial Performance
In 2025, Picard Medical's revenue was $4.94 million, an increase of 12.50% compared to the previous year's $4.39 million. Losses were -$27.00 million, 13.8% more than in 2024.
Financial StatementsNews
Picard Medical Reports Third Quarter 2026 Financial Results; Gross Profit Positive for Third Consecutive Quarter; Net Loss Narrows 79% to $2.2 Million
Picard Medical Reports Third Quarter 2026 Financial Results; Gross Profit Positive for Third Consecutive Quarter; Net Loss Narrows 79% to $2.2 Million
Picard Medical Quarterly report: Q3 2026
Picard Medical has published its Q3 2026 quarterly earnings report on November 16, 2026.
Picard Medical Earnings release: Q3 2026
Picard Medical released its Q3 2026 earnings on November 16, 2026, summarizing the period's financial results.
Picard Medical Registration statement: Registration filing
Picard Medical filed a registration statement on November 5, 2026, providing details about a securities offering with the SEC.
Picard Medical Proxy statement: Proxy filing
Picard Medical filed a proxy statement on November 3, 2026, providing details for shareholder voting and corporate governance matters.
Picard Medical Registration statement: Registration filing
Picard Medical filed a registration statement on October 22, 2026, providing details about a securities offering with the SEC.
Picard Medical Inc trading resumes
11:17 EDT Picard Medical (PMI) Inc trading resumes
Picard Medical Inc trading halted, volatility trading pause
11:12 EDT Picard Medical (PMI) Inc trading halted, volatility trading pause
Picard Medical Inc trading resumes
16:00 EDT Picard Medical (PMI) Inc trading resumes
Picard Medical Inc trading halted, volatility trading pause
15:29 EDT Picard Medical (PMI) Inc trading halted, volatility trading pause
Picard Medical Inc trading resumes
10:24 EDT Picard Medical (PMI) Inc trading resumes
Picard Medical Inc trading halted, volatility trading pause
10:19 EDT Picard Medical (PMI) Inc trading halted, volatility trading pause
Picard Medical Inc trading resumes
09:43 EDT Picard Medical (PMI) Inc trading resumes
Picard Medical Inc trading halted, volatility trading pause
09:38 EDT Picard Medical (PMI) Inc trading halted, volatility trading pause
Picard Medical Slides: Investor presentation
Picard Medical has posted slides in relation to its latest quarterly earnings report, which was published on August 20, 2026.
Picard Medical Reports Second Quarter 2026 Financial Results
- Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE A...
Picard Medical Quarterly report: Q2 2026
Picard Medical has published its Q2 2026 quarterly earnings report on August 19, 2026.
Picard Medical Earnings release: Q2 2026
Picard Medical released its Q2 2026 earnings on August 19, 2026, summarizing the period's financial results.
Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026
–First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform– –First public scientific presen...
Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026
-First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community- TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: P...
Picard Medical announces NYSE acceptance of plan to regain compliance
Picard Medical (PMI) announced that the NYSE has accepted the company’s plan to regain compliance with the exchange’s continued listing standards under Sections 1003 and of the NYSE American Company…
Picard Medical Receives NYSE American Acceptance of Compliance Plan
-Company continues advancing long-term growth strategy under accepted compliance plan- -Company continues advancing long-term growth strategy under accepted compliance plan-
Picard Medical announces 1-for-50 reverse stock split
Picard Medical (PMI) announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company’s issued and outstanding common stock. As disclosed in…
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance
-Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Co...
Picard Medical Proxy statement: Proxy filing
Picard Medical filed a proxy statement on July 16, 2026, providing details for shareholder voting and corporate governance matters.